Compare Orchid Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA DR. REDDYS LAB ORCHID PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -17.3 40.6 - View Chart
P/BV x 2.5 4.4 58.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ORCHID PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-21
DR. REDDYS LAB
Mar-21
ORCHID PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs2,4655,515 44.7%   
Low Rs183,028 0.6%   
Sales per share (Unadj.) Rs110.31,145.4 9.6%  
Earnings per share (Unadj.) Rs-28.5114.5 -24.9%  
Cash flow per share (Unadj.) Rs-1.9188.4 -1.0%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs159.91,053.2 15.2%  
Shares outstanding (eoy) m40.82166.30 24.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.33.7 302.0%   
Avg P/E ratio x-43.537.3 -116.5%  
P/CF ratio (eoy) x-665.622.7 -2,935.4%  
Price / Book Value ratio x7.84.1 191.4%  
Dividend payout %021.8 0.0%   
Avg Mkt Cap Rs m50,677710,289 7.1%   
No. of employees `000NANA-   
Total wages/salary Rs m67136,299 1.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,501190,475 2.4%  
Other income Rs m1522,914 5.2%   
Total revenues Rs m4,653193,389 2.4%   
Gross profit Rs m29438,699 0.8%  
Depreciation Rs m1,08912,288 8.9%   
Interest Rs m522970 53.8%   
Profit before tax Rs m-1,16528,355 -4.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m09,319 0.0%   
Profit after tax Rs m-1,16519,036 -6.1%  
Gross profit margin %6.520.3 32.1%  
Effective tax rate %032.9 0.0%   
Net profit margin %-25.910.0 -259.1%  
BALANCE SHEET DATA
Current assets Rs m5,499145,503 3.8%   
Current liabilities Rs m1,42181,038 1.8%   
Net working cap to sales %90.633.8 267.7%  
Current ratio x3.91.8 215.5%  
Inventory Days Days2061 32.4%  
Debtors Days Days1,10195 1,156.9%  
Net fixed assets Rs m6,874109,979 6.3%   
Share capital Rs m408832 49.1%   
"Free" reserves Rs m6,121174,319 3.5%   
Net worth Rs m6,529175,151 3.7%   
Long term debt Rs m4,2756,299 67.9%   
Total assets Rs m12,373255,482 4.8%  
Interest coverage x-1.230.2 -4.1%   
Debt to equity ratio x0.70 1,820.6%  
Sales to assets ratio x0.40.7 48.8%   
Return on assets %-5.27.8 -66.4%  
Return on equity %-17.810.9 -164.2%  
Return on capital %-6.016.2 -36.8%  
Exports to sales %88.151.3 171.8%   
Imports to sales %37.318.1 206.2%   
Exports (fob) Rs m3,96697,699 4.1%   
Imports (cif) Rs m1,67734,420 4.9%   
Fx inflow Rs m3,96697,699 4.1%   
Fx outflow Rs m1,72934,420 5.0%   
Net fx Rs m2,23763,279 3.5%   
CASH FLOW
From Operations Rs m23635,703 0.7%  
From Investments Rs m672-22,660 -3.0%  
From Financial Activity Rs m-1,650-298 553.7%  
Net Cashflow Rs m-74212,858 -5.8%  

Share Holding

Indian Promoters % 90.0 26.7 336.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.2 49.2 10.5%  
FIIs % 1.8 27.8 6.4%  
ADR/GDR % 0.0 12.1 -  
Free float % 10.0 61.2 16.3%  
Shareholders   34,798 255,720 13.6%  
Pledged promoter(s) holding % 32.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Jan 20, 2022 03:35 PM

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA - GUFIC BIOSCIENCE COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS